|
assessing the efficacy of a multi-strain probiotics in combination with standard care in mild to moderate ulcerative colitis
|
01-10-202330-09-2025
|
Penyelidik Bersama
|
|
a phase 2b/3, randomized, double-blind, placebo-controlled, parallel-group, multicenter protocol to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis
|
18-02-202117-07-2025
|
Penyelidik Bersama
|
|
elucidating the role of gut microbiota in mother with chorioamnionitis
|
01-11-202031-10-2024
|
Penyelidik Bersama
|
|
characterization of multiple omics signatures for in silico personalised colon cancer risk stratification
|
01-11-202031-10-2024
|
Penyelidik Bersama
|
|
a phase 3, multicenter, open-label extension study to evaluate the long term efficacyand safety of mirikizumab in patients with moderately to severely active ulcerativecolitis(protocol no.: i6t-mc-amap)
|
13-10-201912-10-2024
|
Ketua Projek
|
|
exploring diet, physical activities and host’s interaction with colonic mucosal microbiota population in young colorectal cancer
|
24-09-202023-09-2024
|
Penyelidik Bersama
|
|
m16-066:a multicenter,randomized,double-blind,placebo-controlled 52-week maintenance and an open label extension study of the efficacy and safety of risankizumab in subjects with ulcerative colitis who responded to induction treatment in m16-067 0r 065
|
12-09-201911-09-2024
|
Penyelidik Bersama
|
|
m16-067: a multicenter, randomized, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of risankizumab in subjects with moderately to severely active ulcerative colitis who have failed prior biologic therapy
|
12-09-201911-09-2024
|
Penyelidik Bersama
|
|
m16-066:a multicenter,randomized,double-blind,placebo-controlled 52-week maintenance and an open label extension study of the efficacy and safety of risankizumab in subjects with ulcerative colitis who responded to induction treatment in m16-067 0r 065
|
12-09-201911-09-2024
|
Ketua Projek
|
|
m16-067: a multicenter, randomized, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of risankizumab in subjects with moderately to severely active ulcerative colitis who have failed prior biologic therapy
|
12-09-201911-09-2024
|
Ketua Projek
|
|
sensitivity improvement using concentric ring-based metasurface to identify the bio-molecular change in blood cells
|
07-09-202106-09-2024
|
Penyelidik Bersama
|
|
enhancing the electrical conductivity of wearable metamaterial by estimating structural parameters of meanderline-gap shaped unit cell in health garments
|
07-09-202106-09-2024
|
Penyelidik Bersama
|
|
combined phase 3, double-blind, randomized, placebo-controlled studies evaluating the efficacy and safety of filgotinib in the induction and maintenance of remission in subjects with moderately to severely active crohn`s disease
|
16-03-201715-07-2024
|
Ketua Projek
|
|
tocotrienol as a treatment for non-alcoholic fatty liver disease: a randomized controlled trial
|
10-04-202030-06-2024
|
Ketua Projek
|
|
effects of microplastics exposure on gut microenvironment in inflammatory bowel disease
|
16-06-202215-06-2024
|
Ketua Projek
|
|
application of digital technology in personalised strategies for managing non-communicable disease
|
15-06-202114-06-2024
|
Penyelidik Bersama
|
|
m14-675: a multicenter, randomized, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active ulcerative colitis
|
13-06-201912-06-2024
|
Ketua Projek
|
|
the clinical utility of biomarkers afp-l3 and pivka ii as a tool for hepatocellular carcinoma screening in ukmmc
|
24-02-202223-05-2024
|
Ketua Projek
|
|
regulation of mucin, claudin and zonulin in maintaining intestinal barrier function in inflammatory bowel disease
|
01-11-202030-04-2024
|
Penyelidik Bersama
|
|
interactions between the gut microbiota and host intestinal barrier genes in young-onset colorectal cancer
|
01-08-202030-04-2024
|
Penyelidik Bersama
|
|
tajuk program: linking obesity to cancer: an integrative study from molecule to society
tajuk projek: identification of risk factors associated with colon cancer prognosis, disease free survival and recurrence in obese individuals
|
01-02-201931-12-2023
|
Ketua Projek
|
|
elucidating the potential of antimicrobial peptides in inhibiting the growth of antibiotic-resistant helicobacter pylori strains
|
01-09-201930-11-2023
|
Penyelidik Bersama
|
|
modulation of estrobolome by gut microbiota in primary dysmenorrhea rat model
|
01-11-202031-10-2023
|
Penyelidik Bersama
|
|
a phase 3, multicenter, randomized, double-blind, parallel, placebo-controlled induction study of mirikizumab in conventional-failed and biologic-failed patients with moderately to severely active ulcerative colitis(protocol no: 16t-mc-aman)
|
27-12-201826-10-2023
|
Ketua Projek
|
|
impact of probiotics on gut microbiome in postpartum women with history of gestational diabetes mellitus(gdm): comprehensive analysis using predicting modelling towards optimal clinical care
|
01-08-202031-07-2023
|
Penyelidik Bersama
|
|
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of risankizumab in subjects with moderately to severely active crohn`s disease
|
14-09-201713-07-2023
|
Ketua Projek
|
|
gs-us-384-1943: a phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib in subjects with nonalcoholic steatohepatitis (nash) and bridging (f3) fibrosis
|
13-07-201712-07-2023
|
Ketua Projek
|
|
-
|
23-06-202122-06-2023
|
Ketua Projek
|
|
development and clinical evaluation on aptamer-based synthetic antibody for leucine-rich 2-glycoprotein 1 (lrg1) detection in human serum of colorectal cancer
|
01-09-202031-05-2023
|
Penyelidik Bersama
|
|
evaluation of economic burden and healthcare cost of inflammatory bowel disease patients in malaysia
|
26-05-202225-05-2023
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, placebo controlled maintenance and long term extension study of the efficacy and safety of upadacitinib (abt-494) in subjects with crohn’s disease who completed the m14-431 or m14-433 studies
|
12-04-201811-04-2023
|
Ketua Projek
|
|
application of digital technology in personalised strategies for managing non-communicable disease
|
01-10-202131-03-2023
|
Penyelidik Bersama
|
|
a phase 3, multicenter, randomized, double-blind, parallel-arm, placebo-controlled maintenance study of mirikizumab in patients with moderately to severely active ulcerative colitis.protocol no: 16t-mc-ambg
|
27-12-201826-02-2023
|
Ketua Projek
|
|
a phase 3 multicenter, open-label extension (ole) study to evaluate the long-term safety and efficacy of abt-494 in subjects with ulcerative colitis (uc)
|
16-02-201715-02-2023
|
Ketua Projek
|
|
targeting gut-microbiome-brain axis: probiotic have antidepression-like effects and reverse the
impact of chronic stress in rats
|
15-02-201931-12-2022
|
Penyelidik Bersama
|
|
a long-term extension study to evaluate the safety of filgotinib in subjects with ulcerative colitis
|
13-04-201712-12-2022
|
Ketua Projek
|
|
establishing consensus guidelines for biomedical researchers involving clinical trials, community-based and laboratory-based research during and post-pandemic
|
10-12-202009-12-2022
|
Penyelidik Bersama
|
|
a multicenter, randomized, double-blind, placebo-controlled 52-week maintenance and an open-label extension study of the efficacy and safety of risankizumab in subjects with crohn`s disease who responded to induction treatment in m16-006 or m15-991
|
26-10-201725-11-2022
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, placebo-controlled induction study to assess the efficacy and safety of risankizumab in subjects with moderately to severely active crohn`s disease who failed prior biologic treatment
|
14-09-201713-10-2022
|
Ketua Projek
|
|
unravelling driver mutations of phosphatidylinositol 3-kinase pathway genes leading to the development of colitis associated cancer
|
01-01-201930-09-2022
|
Ketua Projek
|
|
assessment of dysphagia in post laryngectomy patient in hospital canselor tuanku muhriz, (hctm,ppukm) : a cross sectional study
|
30-01-202029-06-2022
|
Penyelidik Bersama
|
|
the association between dietary inflammation potential with the risk of colorectal cancer
|
28-12-201927-04-2022
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active crohn`s disease who have inadequately responded to or are intolerant to biologi
|
12-04-201811-04-2022
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active crohn’s disease who have inadequately responded to or are intolerant to
|
12-04-201811-04-2022
|
Ketua Projek
|
|
tocotrienol as a treatment for non-alcoholic fatty liver disease: a randomized controlled trial
|
10-04-202009-04-2022
|
Ketua Projek
|
|
revealing fecal short chain fatty acids as gut microbiota-derived biomarker in non-alcoholic fatty liver disease
|
01-10-201931-03-2022
|
Penyelidik Bersama
|
|
elucidating probiotics as gut microenvironment modulator in non-alcoholic fatty liver disease
|
01-01-201931-03-2022
|
Penyelidik Bersama
|
|
health-related quality of life of inflammatory bowel disease patients in malaysia
|
26-03-202025-03-2022
|
Ketua Projek
|
|
the effectiveness of intestinal ultrasound in the assessment of inflammatory bowel disease: a prospective study at a tertiary ibd centre
|
13-09-201911-03-2022
|
Penyelidik Bersama
|
|
clinical characteristics of colorectal cancer patients in ukmmc from 1997 to 2017
|
22-02-201821-02-2022
|
Ketua Projek
|
|
prevalence of liver injury in covid-19
|
18-02-202117-02-2022
|
Penyelidik Bersama
|
|
inflammatory bowel disease registry data collection for the betterment of ibd patient management
|
18-02-202117-02-2022
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of abt-494 for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis
|
16-02-201715-02-2022
|
Ketua Projek
|
|
combined phase 2b/3, double-blind, randomized, placebo-controlled studies evaluating the efficacy and safety of filgotinib in the induction and maintenance of remission in subjects with moderately to severely active ulcerative colitis
|
13-04-201712-02-2022
|
Ketua Projek
|
|
phase iii, randomized, double-blind, double-dummy, placebo-controlled, multicenter study to evaluate the efficacy (induction of remission) and safety of etrolizumab compared with adalimuman and placebo in patients with moderate to severe ulcerative coliti
|
26-02-201525-12-2021
|
Ketua Projek
|
|
the effect of probiotic as an adjunct treatment for helicobacter pylori infection in adult
|
24-12-202023-12-2021
|
Ketua Projek
|
|
addressing gut health, diet and physical activities : focus on post-gestational diabetes women
|
29-03-201828-09-2021
|
Ketua Projek
|
|
determination of dietary indices , perceived stress and bioindicators as risk factors of colorectal cancer in malaysia-a multicenter case-control study
|
23-07-201921-07-2021
|
Penyelidik Bersama
|
|
real-world practice on the efficacy and safety of antiviral therapy in the management of symptomatic covid-19 infection
|
11-06-202010-06-2021
|
Penyelidik Bersama
|
|
pemantauan secara dekat peluncuran pandemik covid-19 di malaysia menggunakan model seir
|
15-05-202014-05-2021
|
Penyelidik Bersama
|
|
gps-based tracking and monitoring application for high risk covid-19 patients
|
15-05-202014-05-2021
|
Penyelidik Bersama
|
|
the efficacy of nonhdl-c/hdl-c ratio against single measurement of nonhdl-c as a predictive marker in nonalcoholic fatty liver diseases` spectrum
|
14-03-201913-03-2021
|
Penyelidik Bersama
|
|
interventional strategy in tackling emerging non-alcoholic fatty liver disease in childhood obesity
|
15-08-201814-02-2021
|
Penyelidik Bersama
|
|
development of integrated approach for increasing colorectal cancer survivorship prognosis by combining genome integrity, dietary habits, physical activity and psycho social markers.
|
15-08-201814-02-2021
|
Penyelidik Bersama
|
|
exploring effects of replacing white rice with low-gi, polyphenol-rich ukmrc9 red rice on cardiometabolic parameters in patient with type 2 diabetes: a randomized, open-label, 6-month trial
|
14-12-201713-12-2020
|
Penyelidik Bersama
|
|
addressing gut health, diet and physical activities: focus on post-gestational diabetes women
|
01-09-201730-11-2020
|
Ketua Projek
|
|
cross sectional correlational study of mr enterography with clinical, biochemical, double balloon enteroscopy in small bowel disease (crohn disease)
|
30-06-201729-06-2020
|
Penyelidik Bersama
|
|
targeting transcripts related to inflammation in long duration inflammatory bowel disease
|
02-05-201801-05-2020
|
Penyelidik Bersama
|
|
hepatitis b genotyping in chronic hepatitis b patients who are on treatment in ukm medical centre (ukmmc) and the clinical parameters
|
27-04-201726-04-2020
|
Penyelidik Bersama
|
|
knowledge and perceived barrier towards management of hepatitis c infection among government primary care doctors in sabah
|
25-04-201924-04-2020
|
Penyelidik Bersama
|
|
the role and effect of dietary intake variation (low fodmaps diet intervention) on gut microbiota in a multi-ethnic population with irritable bowel syndrome
|
30-03-201929-03-2020
|
Penyelidik Bersama
|
|
the effect of probiotic as adjunct treatment for gastroesophageal reflux disease (gerd) in adults
|
24-12-201823-12-2019
|
Ketua Projek
|
|
prothrombin induced by vitamin k absence-ii (pivka-11) as a diagnostic marker or hepatocellular carcinoma
|
23-02-201722-12-2019
|
Penyelidik Bersama
|
|
a novel approach to manipulate intestinal homeostasis in primary dysmenorrhea women
|
10-05-201809-11-2019
|
Penyelidik Bersama
|
|
targeting transcripts related to inflammation in long duration inflammatory bowel disease
|
16-10-201715-10-2019
|
Penyelidik Bersama
|
|
the effectiveness of probiotics on constipation in parkinson disease: rct
|
06-10-201805-10-2019
|
Penyelidik Bersama
|
|
probiotics as an adjunct treatment for management of acute gastroenteritis in children less than 5 years old-a randomized double-blinded controlled clinical trial
|
25-09-201824-09-2019
|
Penyelidik Bersama
|
|
an evaluation of cultured milk drink on immune status of patients with irritable bowel syndrome : constipation-predominant
|
11-05-201710-05-2019
|
Ketua Projek
|
|
thiopurine metabolites in inflammatory bowel disease: optimising correlation with disease activity and identification of novel genetic factors that govern treatment outcome
|
24-10-201623-04-2019
|
Penyelidik Bersama
|
|
identification of mir-182, mir-301a, and mir-373 as potential biomarkers in non-alcoholic steatohepatitis induced liver cirrhosis with or without hepatocellular carcinoma
|
05-04-201804-04-2019
|
Penyelidik Bersama
|
|
analysis of cluster of differentiation (cd) antigens in h. pylori-associated gastric cancer and non-gastric cancer
|
01-01-201731-12-2018
|
Penyelidik Bersama
|
|
the impact and effectiveness of clinical pathway in outpatient management of irritable bowel syndrome universiti kebangsaan malaysia medical centre (ukmmc)
|
14-12-201713-12-2018
|
Ketua Projek
|
|
evaluating the effect of probiotics among elderly patients with constipation and multiple chronic co-morbidities
|
01-12-201630-11-2018
|
Penyelidik Bersama
|
|
assessment of correlation between non alcoholic fatty liver disease and severity of coronary artery disease in young acute coronary syndrome in ukmmc
|
30-11-201729-11-2018
|
Ketua Projek
|
|
hepatitis b genotype in chronic hepatitis b patients not on treatment in ukmmc
|
30-03-201729-11-2018
|
Penyelidik Bersama
|
|
the role of azathioprine metabolites in clinical management of adult inflammatory bowel disease patients at ukmmc
|
15-09-201614-10-2018
|
Ketua Projek
|
|
prevalence of irritable bowel syndrome in urban setting
|
30-03-201729-09-2018
|
Penyelidik Bersama
|
|
tajuk program: gut microbiome: the exciting new frontier in understanding colorectal cancer
tajuk projek: an evaluation of probiotic influence in the clinical course of patients with colorectal cancer
|
01-02-201531-07-2018
|
Ketua Projek
|
|
tajuk program: gut microbiome: the exciting new frontier in understanding colorectal cancer
tajuk projek: an evaluation of probiotic influence in the clinical course of patients with colorectal cancer
|
01-02-201531-07-2018
|
Ketua Program
|
|
tajuk program: gut microbiome: the exciting new frontier in understanding colorecteral cancer
tajuk projek: mapping of gut microbiome secretome in colorectal cancer
|
01-02-201531-07-2018
|
Ketua Program
|
|
tajuk program: gut microbiome: the exciting new frontier in understanding colorecteral cancer. tajuk projek: elucidating the colorecteral cancer gut microbiome
|
01-02-201531-07-2018
|
Ketua Program
|
|
an exaluation on the effect of cultured milk drink with added polydextrose in constipated adults
|
01-06-201630-06-2018
|
Ketua Projek
|
|
elucidating the mechanisms in early onset of inflammatory bowel disease (ibd) resulting in the multiple complications campared to late onset ibd
|
02-11-201531-05-2018
|
Ketua Projek
|
|
paradigm of clinical characterics among ibd patients and ibd associated neoplasia in a malaysian multi ethic cohort
|
11-05-201710-04-2018
|
Ketua Projek
|
|
infective pathogens in inflammatory bowel disease patients in a tertiary medical centre
|
30-03-201729-03-2018
|
Penyelidik Bersama
|
|
liver abscess - a 15 years retrospective analysis of the trend and clinical outcome in national university of malaysia hospital (ppukm)
|
14-09-201713-01-2018
|
Ketua Projek
|
|
nutritional status, dietary practices and beliefs among ulcerative colitis (uc) patients in hospital canselor tuanku muhriz (hctm)
|
13-07-201712-01-2018
|
Penyelidik Bersama
|
|
gut microbiome: the exciting new frontier in understanding colorectal cancer
|
01-01-201531-12-2017
|
Ketua Projek
|
|
characterisation of transcription binding motifs of metastamir in metastatic cancers
|
01-07-201431-12-2017
|
Penyelidik Bersama
|
|
serum mirna profiling in malay early onset-parkinson’s disease
|
01-06-201531-05-2017
|
|
|
an evaluation of endoscopic findings among geriatric patient with chronic kidney disease and anemia in ukmmc
|
14-04-201613-04-2017
|
Ketua Projek
|
|
dietary and lifestyle risk factors of non-alcoholic fatty liver disease (nafld) among outpatients in hospital canselor tuanku muhkriz
|
11-08-201610-03-2017
|
Penyelidik Bersama
|
|
cost effectiveness analysis of colorectal cancer screening in malaysia
|
01-03-201628-02-2017
|
Penyelidik Bersama
|
|
knowledge, attitude and practice towards colorectal cancer screening among primary care physicians
|
01-09-201631-12-2016
|
Ketua Projek
|
|
the utility of serum biomarkers in diagnosing pre-malignant lesions in the stomach
|
01-08-201331-12-2016
|
Ketua Projek
|
|
diagnostic value of fecal calprotectin in determining disease activity in patients with inflammatory bowel disease patients at ukmmc
|
01-04-201331-12-2016
|
Ketua Projek
|
|
graphene-based spontaneous polymeric micelles as a novel carrier for drug delivery system
|
01-08-201431-07-2016
|
Penyelidik Bersama
|
|
the utility of serum biomarkers in diagnosing pre-malignant lesions in the stomach
|
25-06-201524-06-2016
|
Ketua Projek
|
|
determination of the prevalence of chronic hepatitis b infection among antenatal patients attending antenatal clinic in ukm medical centre and to establish a clinical care pathway for these antenatal patients detected to have chronic hepatitis b in ukmmc
|
27-08-201526-01-2016
|
Penyelidik Bersama
|
|
assessment of quality of life in relation to disease activity index among patients with inflammatory bowel disease at ukm medical centre
|
29-01-201528-11-2015
|
Ketua Projek
|
|
an evaluation on the effect of yogurt drink with added inulin in healthy and constipated adults: an industrial research partnership between permanis sdn bhd & universiti kebangsaan malaysia.
|
01-04-201530-09-2015
|
Ketua Projek
|
|
head-to-head comparison of sensitivity and specificity of fecal tumor-specific pyruvate kinase (m2-pk) and colonoscopy in detecting colorectal adenomas and carcinomas in low to high risk patients
|
23-01-201422-07-2015
|
Penyelidik Bersama
|
|
diagnostic value of fecal calprotectin in determining disease activity in inflammatory bowel disease patients at ukmmc
|
16-05-201415-04-2015
|
Penyelidik Bersama
|
|
molecular chaharacterisation of triple negative breast cancer
|
01-04-201431-03-2015
|
Penyelidik Bersama
|
|
non-alcoholic fatty liver disease : prevalence, relationship with metabolic syndrome and serum fragmented ck-18 level : a case control study
|
01-06-201431-12-2014
|
Penyelidik Bersama
|
|
prevalence of depression and suicidal ideation among patients with chronic inflammatory bowel disease at ukm medical centre
|
08-04-201407-07-2014
|
Penyelidik Bersama
|
|
-
|
24-12-2019
|
Penyelia
|